Timing of surgery in patients with synchronous colorectal cancer liver metastases undergoing neoadjuvant chemotherapy: a propensity score analysis

[1]  Xinxiang Li,et al.  Effect of interval between neoadjuvant chemoradiotherapy and surgery on oncological outcomes in poor responders with locally advanced rectal cancer: a retrospective cohort study , 2023, International journal of surgery.

[2]  [China guideline for diagnosis and comprehensive treatment of colorectal liver metastases (version 2023)]. , 2023, Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery.

[3]  Y. Takeda,et al.  Clinical outcomes of neoadjuvant chemotherapy for resectable colorectal liver metastasis with intermediate risk of postoperative recurrence: A multi‐institutional retrospective study , 2022, Annals of gastroenterological surgery.

[4]  P. Paty,et al.  Colorectal cancer , 2022, Journal of surgical oncology.

[5]  E. Chen,et al.  Surgical timing after preoperative chemotherapy is associated with oncologic outcomes in resectable colorectal liver metastases , 2022, Journal of surgical oncology.

[6]  Fei Liu,et al.  Laparoscopic liver resection for hepatocellular carcinoma presents less respiratory complications compared with open procedure: A propensity score analysis in the elderly. , 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[7]  S. Gardiner,et al.  Time to surgery following neoadjuvant chemotherapy for breast cancer impacts residual cancer burden, recurrence, and survival , 2020, Journal of surgical oncology.

[8]  S. Chia,et al.  Impact of wait time from neoadjuvant chemotherapy to surgery in breast cancer: Does time to surgery affect patient outcomes? , 2020, Breast Cancer Research and Treatment.

[9]  J. Cai,et al.  From the completion of neoadjuvant chemotherapy to surgery for colorectal cancer liver metastasis: What is the optimal timing? , 2020, Cancer medicine.

[10]  K. Matsuo,et al.  Mild Prognostic Impact of Postoperative Complications on Long-term Survival of Perihilar Cholangiocarcinoma , 2020, Annals of surgery.

[11]  G. Sideris,et al.  The role of liver transplantation for colorectal liver metastases: A systematic review and pooled analysis. , 2020, Transplantation reviews.

[12]  J. Vauthey,et al.  Surgical approach to synchronous colorectal liver metastases: staged, combined, or reverse strategy. , 2020, Hepatobiliary surgery and nutrition.

[13]  J. Reeves,et al.  Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI-Bevacizumab Versus FOLFOX-Bevacizumab for Metastatic Colorectal Cancer (STEAM). , 2019, The oncologist.

[14]  W. Messersmith.  NCCN Guidelines Updates: Management of Metastatic Colorectal Cancer. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

[15]  Zachary L. Skidmore,et al.  NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor–Positive Breast Cancer , 2017, Clinical Cancer Research.

[16]  Ahmed Kamel,et al.  Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

[17]  I. Nagtegaal,et al.  Treatment Interval between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer Patients: A Population-Based Study , 2016, Annals of Surgical Oncology.

[18]  J. Boughey,et al.  The timing of breast and axillary surgery after neoadjuvant chemotherapy for breast cancer. , 2016, Chinese clinical oncology.

[19]  L. Påhlman,et al.  Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. , 2015, Cancer treatment reviews.

[20]  M. Koch,et al.  Chemotherapy-associated liver injury and its influence on outcome after resection of colorectal liver metastases. , 2014, Surgery.

[21]  C. Buskens,et al.  Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer , 2013, British Journal of Surgery.

[22]  A. Stenzinger,et al.  Postoperative Complications Deteriorate Long-Term Outcome in Pancreatic Cancer Patients , 2012, Annals of Surgical Oncology.

[23]  S. Curley,et al.  Extended Preoperative Chemotherapy Does Not Improve Pathologic Response and Increases Postoperative Liver Insufficiency After Hepatic Resection for Colorectal Liver Metastases , 2010, Annals of Surgical Oncology.

[24]  Wei Wei,et al.  Metastatic patterns in adenocarcinoma , 2006, Cancer.

[25]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[26]  P. Lodge,et al.  Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver (Br J Surg 2003; 90: 963‐969) , 2003, The British journal of surgery.

[27]  F. Lévi,et al.  Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver , 2003, The British journal of surgery.

[28]  L. Wyrwicz,et al.  Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[29]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..